Evolutionary Genomics, Inc. (FNAM) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
4220 MORNINGSTAR DRIVE CASTLE ROCK, CO 80108 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8731 - Commercial Physical and Biological Research (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 765,550 | 897,779 | 1,042,290 | 214,009 | 605,508 | 588 | |||
| Cash and cash equivalents | 765,550 | 897,779 | 1,042,290 | 214,009 | 605,508 | 588 | |||
| Prepaid expense | 11,652 | 26,457 | 41,762 | 41,792 | 24,293 | 41,293 | |||
| Other undisclosed current assets | |||||||||
| Total current assets: | 777,202 | 924,236 | 1,084,052 | 255,801 | 629,801 | 41,881 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 7,641 | 11,327 | 15,013 | 18,698 | 26,714 | 34,730 | |||
| Intangible assets, net (including goodwill) | 1,902,529 | 2,154,217 | 2,405,905 | 2,657,592 | 2,909,280 | 3,160,968 | |||
| Intangible assets, net (excluding goodwill) | 1,902,529 | 2,154,217 | 2,405,905 | 2,657,592 | 2,909,280 | 3,160,968 | |||
| Total noncurrent assets: | 1,910,170 | 2,165,544 | 2,420,918 | 2,676,290 | 2,935,994 | 3,195,698 | |||
| TOTAL ASSETS: | 2,687,372 | 3,089,780 | 3,504,970 | 2,932,091 | 3,565,795 | 3,237,579 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 158,527 | 93,844 | 56,147 | 18,866 | 39,655 | 129,233 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 1,522,970 | 1,450,404 | 1,379,012 | ||
| Accrued liabilities | |||||||||
| Other undisclosed accounts payable and accrued liabilities | 158,527 | 93,844 | 56,147 | (1,504,104) | (1,410,749) | (1,249,779) | |||
| Total current liabilities: | 158,527 | 93,844 | 56,147 | 18,866 | 39,655 | 129,233 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 3,743,747 | 3,743,747 | 3,743,747 | 3,743,747 | 3,743,747 | 2,322,226 | |||
| Long-term debt, excluding current maturities | 3,743,747 | 3,743,747 | 3,743,747 | 3,743,747 | 3,743,747 | 2,322,226 | |||
| Other undisclosed noncurrent liabilities | (37,140) | ||||||||
| Total noncurrent liabilities: | 3,743,747 | 3,743,747 | 3,706,607 | 3,743,747 | 3,743,747 | 2,322,226 | |||
| Total liabilities: | 3,902,274 | 3,837,591 | 3,762,754 | 3,762,613 | 3,783,402 | 2,451,459 | |||
| Temporary equity, carrying amount | 4,023,598 | 4,023,598 | 4,023,598 | 3,569,594 | 3,569,594 | 3,569,594 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (5,238,500) | (4,771,409) | (4,318,522) | (4,400,116) | (3,787,201) | (2,783,474) | |||
| Preferred stock | 1,592,571 | 1,521,796 | 1,450,404 | 1,379,012 | |||||
| Common stock | 6,655 | 6,655 | 6,615 | 5,882 | 5,882 | 5,882 | |||
| Additional paid in capital | 12,479,601 | 12,482,548 | 12,484,653 | 11,949,702 | 11,966,165 | 11,982,627 | |||
| Accumulated deficit | (19,478,711) | (18,933,434) | (18,402,361) | (17,877,496) | (17,209,652) | (16,150,995) | |||
| Other undisclosed equity, attributable to parent | 1,753,955 | 1,672,822 | |||||||
| Other undisclosed equity | 37,140 | ||||||||
| Total equity: | (5,238,500) | (4,771,409) | (4,281,382) | (4,400,116) | (3,787,201) | (2,783,474) | |||
| TOTAL LIABILITIES AND EQUITY: | 2,687,372 | 3,089,780 | 3,504,970 | 2,932,091 | 3,565,795 | 3,237,579 | |||
Income Statement (P&L) (USD)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (545,681) | (531,432) | (524,944) | (668,079) | (1,142,307) | (553,707) | ||
| Operating loss: | (545,681) | (531,432) | (524,944) | (668,079) | (1,142,307) | (553,707) | ||
| Nonoperating income | 404 | 359 | 79 | 235 | 83,650 | 6 | ||
| Investment income, nonoperating | 404 | 359 | 79 | 235 | 255 | 6 | ||
| Loss from continuing operations: | (545,277) | (531,073) | (524,865) | (667,844) | (1,058,657) | (553,701) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (545,277) | (531,073) | (524,865) | (667,844) | (1,058,657) | (553,701) | |
| Net loss attributable to parent: | (545,277) | (531,073) | (524,865) | (667,844) | (1,058,657) | (553,701) | ||
| Preferred stock dividends and other adjustments | (81,133) | (80,251) | (71,392) | (71,392) | (71,392) | |||
| Other undisclosed net loss available to common stockholders, basic | (70,775) | |||||||
| Net loss available to common stockholders, basic: | (626,410) | (611,324) | (595,640) | (739,236) | (1,130,049) | (625,093) | ||
| Convertible preferred dividends | (70,775) | |||||||
| Net loss available to common stockholders, diluted: | (626,410) | (611,324) | (666,415) | (739,236) | (1,130,049) | (625,093) | ||
Comprehensive Income (USD)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (545,277) | (531,073) | (524,865) | (667,844) | (1,058,657) | (553,701) | ||
| Other undisclosed comprehensive loss | (15,182) | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (545,277) | (531,073) | (524,865) | (683,026) | (1,058,657) | (553,701) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.